Shareholders of Outset Medical, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights – OM

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Outset Medical, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Tablo products used in dialysis care [1][2]. Summary by Sections Class Period and Allegations - The class period for the lawsuit is from August 1, 2022, to August 7, 2024 [2]. - Allegations include that Outset Medical marketed its Tablo products for uses not approved by the FDA, which could lead to a need for additional regulatory applications [2]. - There is a substantial risk that the company may have to cease sales of Tablo products pending FDA approval for additional indications [2]. - The company reportedly lacked the necessary sales team and processes to effectively ramp up Tablo sales, which would adversely impact revenue growth [2]. - Positive statements made by the defendants regarding the company's business and prospects were claimed to be materially misleading [2]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of October 28, 2024, to potentially become lead plaintiffs [3]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].